latest update:
[TrialBase DB]

trial summary · NCT07292298

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

Trial record from the TrialBase DB dataset, status RECRUITING, condition Rectal Adenocarcinoma, sponsored by University of Colorado, Denver. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07292298phase PHASE2enrollment 44start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Rectal cancer patients who do not achieve a complete response to standard of care chemotherapy and radiation often require surgical resection as part of curative intent therapy. This study will evaluate whether additional "focal" radiation delivered internally (rectal brachytherapy) can provide complete responses and thus spare the requirement for surgery. The main questions are whether: 1) rectal brachytherapy is safe in this clinical treatment paradigm and if 2) rectal brachytherapy improves organ preservation (no need for surgery). The trial involves an additional MRI pelvis and sigmoidoscopy with marker placement to define high-risk residual disease for radiation planning. Subsequently, 3 outpatient brachytherapy treatments are given on a weekly basis. If a patient achieves a complete response to brachytherapy, standard of care non-operative surveillance visits are conducted with study visits aligned during the first two years following brachytherapy.

Source record: https://clinicaltrials.gov/study/NCT07292298

Facts

registry idNCT07292298
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionRectal Adenocarcinoma
sponsorUniversity of Colorado, Denver
sponsor classOTHER
enrollment44
start date2026-11
primary completion2030-11
completion2031-11
results postednot reported

Conditions

  • Rectal Adenocarcinoma
  • Rectal Cancer

Interventions

  • High Rare Dose Rectal Brachytherapy Boost

Countries

  • United States

Intervention types: RADIATION

Work with this record